Keros Therapeutics, Inc.
KROS · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$7 | -$31 | $148 | -$46 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $4 | $9 | $9 | $9 |
| Change in WC | $6 | -$8 | $3 | -$10 |
| Other Non-Cash | $1 | $1 | $1 | $1 |
| Operating Cash Flow | $3 | -$30 | $161 | -$46 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$1 | -$1 | -$0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$0 | -$1 | -$1 | -$0 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $73 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $0 | $2 |
| Financing Cash Flow | $0 | $0 | $0 | $76 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $3 | -$30 | $161 | $29 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $692 | $722 | $561 | $532 |
| End Cash | $695 | $692 | $722 | $561 |
| Free Cash Flow | $3 | -$30 | $161 | -$46 |